The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD
In COPD, the activity of the cholinergic system is increased, which is one of the reasons for the airflow limitation caused by the contraction of airway smooth muscles. Therefore, blocking the contractive actions with anticholinergics is a useful therapeutic intervention to reduce the airflow limita...
Saved in:
Main Authors: | Mitsuhiro Yamada (Author), Masakazu Ichinose (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological and Electroceutical Targeting of the Cholinergic Anti-Inflammatory Pathway in Autoimmune Diseases
by: Moncef Zouali
Published: (2023) -
Advances of Fibroblast Growth Factor/Receptor Signaling Pathway in Hepatocellular Carcinoma and its Pharmacotherapeutic Targets
by: Haijun Wang, et al.
Published: (2021) -
The Cholinergic Anti-Inflammatory Pathway as a Conceptual Framework to Treat Inflammation-Mediated Renal Injury
by: Jonas Jarczyk, et al.
Published: (2019) -
Cholinergic Anti-Inflammatory Pathway and the Liver
by: Khalil Hajiasgharzadeh, et al.
Published: (2017) -
The Kappa Opioid Receptor: Candidate Pharmacotherapeutic Target for Multiple Sclerosis
by: Brian Reed, et al.
Published: (2023)